Related Experiment Video

Updated: Jul 8, 2025

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

292

Corrigendum: Risk and prediction of multiple primary malignancies after early gastric cancer

Na Chen1, Lei Shi1, Jian Ge1

  • 1Department of Gastroenterology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China.

Frontiers in Oncology
|December 14, 2023
PubMed

Abstract:

[This corrects the article DOI: 10.3389/fonc.2023.1205358.].

Keywords:
early gastric cancermultiple primary malignanciesnomogrampredictive factorpredictive tool

More Related Videos

Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors
03:05

Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors

Published on: February 16, 2024

1.1K
Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer
07:50

Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer

Published on: September 18, 2020

5.6K

Related Experiment Videos

Last Updated: Jul 8, 2025

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

292
Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors
03:05

Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors

Published on: February 16, 2024

1.1K
Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer
07:50

Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer

Published on: September 18, 2020

5.6K

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

355
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
355

Articles linked to this work by shared authors, journal, and citation graph.

Integrated EBV and host DNA methylation profiling identifies distinct candidate EBV-host junction patterns in chronic active EBV infection.

Microbiology spectrum·2026

A two-phase low-dose ACD-A strategy overcomes hypocalcemia during peripheral blood stem cell collection: a randomized controlled study.

Frontiers in oncology·2026

ICANS After CAR-T Therapy: Mechanisms and Management With a Focus on Corticosteroid-Refractory ICANS.

Immunology·2026

Adaptation and psychometric properties of the Coping Flexibility Scale-Revised in Chinese parents of children with cancer.

BMC psychology·2026

Refinement and application of 12S rRNA meta-barcoding primers for seafood identification in multispecies product.

Current research in food science·2026

Enhancement of ursolic acid (UA), an active ingredient in hawthorn, on the uptake and metabolism of 2,3,5,4'-tetrahydroxystilbene-2-O-β-D-glucoside (THSG) derived from Polygonum multiflorum.

Food research international (Ottawa, Ont.)·2026

Hypofractionated radiotherapy in head and neck cancer: current evidence and future directions, with a focus on laryngeal cancer.

Frontiers in oncology·2026

CPT1A as a metabolic gatekeeper linking fatty acid oxidation, ferroptosis resistance, and breast cancer stemness.

Frontiers in oncology·2026

Developmentally relevant proteins contribute to chemotherapeutic resistance in neuroblastoma.

Frontiers in oncology·2026

Advances in the application of gene methylation detection in cervical cancer screening.

Frontiers in oncology·2026

Prospective multicenter study evaluating safety, tolerability and metabolism of niraparib as maintenance for ovarian cancer in women of African ancestry.

Frontiers in oncology·2026

TET1 loss promotes malignant phenotypes in HeLa cells and is associated with altered PTEN-PI3K/AKT/mTOR signaling.

Frontiers in oncology·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us